Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Clinical Medicine Insights. Case Reports|March 28, 2020
A Case of Bilateral Acute Inferior Limb Ischemia in a Patient With Ulcerative ColitisMimari Kanazawa, Takeshi Sugaya, Fumiaki Takahashi, et al.Medicina (Kaunas, Lithuania)|February 25, 2022
A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative ColitisMimari Kanazawa, Keiichi Tominaga, Akira Kanamori, et al.Clinical Journal of Gastroenterology|September 8, 2025
Crohn's disease exacerbated by ghost pills of upadacitinibChihiro Yunomura, Shunsuke Kojimahara, Keiichi Tominaga, et al.Medicina (Kaunas, Lithuania)|November 11, 2020
A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative ColitisKeiichi Tominaga, Mimari Kanazawa, Takanao Tanaka, et al.Scientific Reports|November 30, 2019
Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitisKazuhiro Takenaka, Keiichi Tominaga, Mimari Kanazawa, et al.World Journal of Gastroenterology|March 23, 2022
Curative resection with endoscopic submucosal dissection of early gastric cancer in Helicobacter pylori-negative Ménétrier's disease: A case reportKoh Fukushi, Kenichi Goda, Hitoshi Kino, et al.Clinical Journal of Gastroenterology|October 7, 2020
Gastric Dieulafoy's lesion with subepithelial lesion-like morphologyTakanao Tanaka, Takeshi Sugaya, Keiichi Tominaga, et al.Digestion|July 13, 2022
Making Hematochezia of Unknown Origin Known: A Retrospective AnalysisTakanao Tanaka, Keiichi Tominaga, Akira Yamamiya, et al.Digestion|June 12, 2026
Prognostic effect of MES 1 inflammatory extent on remission maintenance in ulcerative colitisMimari Kanazawa, Keiichi Tominaga, Takanao Tanaka, et al.Healthcare (Basel, Switzerland)|April 30, 2021
Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case ReportYasuhito Kunogi, Keiichi Tominaga, Keiichiro Abe, et al.Pageof 3